In an accompanying commentary, Joseph Witztum discusses potential reasons for the discordant results. He mentions that the reasons why the data are different from previous studies is not quite clear, but that the "data presented by Moore, et al. will cause all of us to stop and reevaluate and to undertake much more experimentation and thought."
TITLE: Loss of lipid uptake via class A scavenger receptors or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
AUTHOR CONTACT:
Mason Freeman
Massachusetts General Hospital, Boston, MA USA
Phone: 617-726-5906; Fax: 617-726-2879; E-mail: freeman@molbio.mgh.harvard.edu
View the PDF of this article at: https://www.the-jci.org/article.php?id=24061
ACCOMPANYING COMMENTARY:
TITLE: You are right too!
AUTHOR CONTACT:
Joseph L. Witztum
University of California San Diego, La Jolla, CA USA
Phone: 858-534-4347; Fax: 858-534-4347; E-mail: jwitztum@ucsd.edu
View the PDF of this article at: https://www.the-jci.org/article.php?id=26130
'"/>
Contact: Stacie Bloom
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
1-Aug-2005